Nxera Pharma Co., Ltd. (TYO:4565)
Japan
· Delayed Price · Currency is JPY 900.00
+15.00 (1.69%)
Apr 25, 2025, 11:30 AM JST
Nxera Pharma Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -4,662 | -10,680 | 1,078 | 433 | 1,622 | Upgrade
|
| Depreciation & Amortization | 3,984 | 2,478 | 1,345 | 1,278 | 1,350 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 3,138 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 5 | 1,363 | 1,877 | -208 | -111 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | 429 | -50 | 356 | Upgrade
|
| Other Operating Activities | 28 | -942 | 338 | 486 | 1,325 | Upgrade
|
| Change in Accounts Receivable | -742 | 1,315 | -210 | -799 | 752 | Upgrade
|
| Change in Inventory | -5,935 | 1,908 | - | - | - | Upgrade
|
| Change in Accounts Payable | -487 | 1,552 | 315 | -184 | 61 | Upgrade
|
| Change in Other Net Operating Assets | 91 | -2,267 | 4,780 | 3,001 | -683 | Upgrade
|
| Operating Cash Flow | -7,718 | -5,273 | 9,952 | 7,095 | 4,672 | Upgrade
|
| Operating Cash Flow Growth | - | - | 40.27% | 51.86% | 35.77% | Upgrade
|
| Capital Expenditures | -526 | -804 | -277 | -193 | -92 | Upgrade
|
| Cash Acquisitions | - | -62,941 | - | - | - | Upgrade
|
| Divestitures | - | - | - | 206 | -577 | Upgrade
|
| Sale (Purchase) of Intangibles | -1,011 | -47 | -26 | -8 | -13 | Upgrade
|
| Investment in Securities | -3,870 | - | 1,209 | - | 238 | Upgrade
|
| Other Investing Activities | 644 | 1 | 137 | 273 | 294 | Upgrade
|
| Investing Cash Flow | -4,763 | -63,791 | 1,043 | 278 | -150 | Upgrade
|
| Long-Term Debt Issued | - | 71,608 | - | 29,855 | 15,902 | Upgrade
|
| Long-Term Debt Repaid | -5,800 | -1,450 | - | - | - | Upgrade
|
| Total Debt Repaid | -5,800 | -1,450 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -5,800 | 70,158 | - | 29,855 | 15,902 | Upgrade
|
| Issuance of Common Stock | - | 9,983 | - | 600 | 5,145 | Upgrade
|
| Other Financing Activities | -1,054 | -31,812 | -4,887 | -19,332 | -769 | Upgrade
|
| Financing Cash Flow | -6,854 | 48,329 | -4,887 | 11,123 | 20,278 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2,538 | 3,243 | 362 | 1,583 | -167 | Upgrade
|
| Net Cash Flow | -16,797 | -17,492 | 6,470 | 20,079 | 24,633 | Upgrade
|
| Free Cash Flow | -8,244 | -6,077 | 9,675 | 6,902 | 4,580 | Upgrade
|
| Free Cash Flow Growth | - | - | 40.18% | 50.70% | 44.48% | Upgrade
|
| Free Cash Flow Margin | -28.59% | -47.60% | 62.14% | 38.97% | 51.80% | Upgrade
|
| Free Cash Flow Per Share | -91.87 | -73.65 | 117.14 | 84.17 | 57.62 | Upgrade
|
| Cash Interest Paid | 435 | 241 | 171 | 157 | 60 | Upgrade
|
| Cash Income Tax Paid | 269 | 1,394 | 262 | -87 | -1,170 | Upgrade
|
| Levered Free Cash Flow | -9,249 | -11,530 | -1,367 | 8,544 | 4,514 | Upgrade
|
| Unlevered Free Cash Flow | -8,768 | -11,038 | -946.5 | 8,868 | 4,644 | Upgrade
|
| Change in Net Working Capital | 7,075 | 6,166 | 3,746 | -3,472 | -2,865 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.